A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Summary

The objectives of this study are to evaluate the therapeutic efficacy and safety of DSXS and a Placebo in patients with moderate to severe scalp psoriasis.

Timeline

Start

2015-04

Primary completion

2015-09-14

Completion

2016-01-29

Outcome

Met primary endpoint

registry analysis (superiority test); DSXS1411 30 Min vs Placebo 30 Min; p = .0325; Cochran-Mantel-Haenszel NCT02413229 ↗

Drugs

Indications